Last update:

Clinical pharmacology news

Common anti-seizure drug prevents Alzheimer's plaques from forming, study shows

While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in the brain, they have struggled to understand how these harmful fragments are produced. Now, in a ...

Single DMT dose treats stress-induced depression more effectively than Prozac in mice

Psychedelics are psychoactive substances that trigger unusual mental states, also referred to as "trips," altering the perceptions, thoughts, and emotions of those taking them and typically inducing hallucinations. Over the ...

Tiny worm offers clues to combat chemotherapy neurotoxicity

Chemotherapy remains one of the most powerful tools in the fight against cancer, yet it often comes with significant long-term side effects that can dramatically affect patients' quality of life. Among the most debilitating ...

Established cancer drug can reactivate immunotherapy

Genetically modified immune cells can offer precious additional time to patients with advanced multiple myeloma. However, these therapies lose their impact as the molecules on cancer cells that immune cells recognize gradually ...

First of its kind daily HIV treatment shows promising results

Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer inhibitor (INSTI) single tablet treatment for HIV, among growing concern for the potential of widespread ...

AI model can accelerate antibody drug production

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions. With the market for these therapies forecast to double ...